Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diagnosis of Myeloproliferative Neoplasia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT00002549
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia

Who this might be right for
Leukemia
European Organisation for Research and Treatment of Cancer - EORTC 1,520
Not applicableLooking for participantsNCT07165535
What this trial is testing

Quality of Life and Care Organization of Patients With Chronic Myeloid Leukemia in the Lombardy Hematology Network

Who this might be right for
Chronic Myeloid Leukemia (CML)
University of Milano Bicocca 2,000
Not applicableStudy completedNCT00666289
What this trial is testing

Familial Myeloproliferative Disorders

Who this might be right for
Polycythemia VeraEssential ThrombocythemiaIdiopathic Myelofibrosis
Icahn School of Medicine at Mount Sinai 17
Testing effectiveness (Phase 2)Looking for participantsNCT05564390
What this trial is testing

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative NeoplasmAcute Myeloid Leukemia Post Cytotoxic Therapy+2 more
National Cancer Institute (NCI)
Early research (Phase 1)Ended earlyNCT02047149
What this trial is testing

Evaluating the Safety of Zileuton (Zyflo®) in Combination With Dasatinib (Sprycel®) in Chronic Myelogenous Leukemia

Who this might be right for
Chronic Myelogenous Leukemia
University of Massachusetts, Worcester 2
Early research (Phase 1)Ended earlyNCT00907517
What this trial is testing

Study of SCH 900776 (MK-8776) With and Without Cytarabine in Participants With Acute Leukemias (P05247)

Who this might be right for
Myelogenous Leukemia, AcuteLeukemia, Lymphocytic, AcuteLeukemia, Lymphoblastic, Acute, Philadelphia-Positive+1 more
Merck Sharp & Dohme LLC 24
Testing effectiveness (Phase 2)Study completedNCT00132015
What this trial is testing

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
National Institutes of Health Clinical Center (CC) 37
Testing effectiveness (Phase 2)Study completedNCT03149055
What this trial is testing

Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT)

Who this might be right for
Hematologic MalignancyMyeloproliferative Disorder
Memorial Sloan Kettering Cancer Center 99
Early research (Phase 1)Study completedNCT01031368
What this trial is testing

Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+15 more
Nohla Therapeutics, Inc. 29
Testing effectiveness (Phase 2)Temporarily pausedNCT01211691
What this trial is testing

Study of KB004 in Subjects With Hematologic Malignancies (Myelodysplastic Syndrome, MDS, Myelofibrosis, MF)

Who this might be right for
Myelodysplastic Syndrome (MDS)Myelofibrosis (MF)
Humanigen, Inc. 120
Not applicableUnknownNCT03131986
What this trial is testing

Cessation of Tyrosine Kinase Inhibitors in Patients With Chronic-phase Chronic Myelogenous Leukaemia

Who this might be right for
Leukemia, Myelogenous, Chronic Phase
The University of Hong Kong 30
Testing effectiveness (Phase 2)Study completedNCT00119340
What this trial is testing

Fludarabine, Total-Body Irradiation, and Donor Stem Cell Transplant Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Fred Hutchinson Cancer Center 75
Early research (Phase 1)WithdrawnNCT02871323
What this trial is testing

Durvalumab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis

Who this might be right for
Polycythemia Vera, Post-Polycythemic Myelofibrosis PhasePrimary Myelofibrosis
Northwestern University
Early research (Phase 1)Study completedNCT00006213
What this trial is testing

BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia

Who this might be right for
Adult Acute Promyelocytic Leukemia (M3)Blastic Phase Chronic Myelogenous LeukemiaChildhood Myelodysplastic Syndromes+8 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Ended earlyNCT01130688
What this trial is testing

Safety of Zileuton (Zyflo) in Combination With Imatinib Mesylate (Gleevec) in CML.

Who this might be right for
Chronic Myelogenous Leukemia
University of Massachusetts, Worcester 2
Testing effectiveness (Phase 2)Study completedNCT02397720
What this trial is testing

Nivolumab and Azacitidine With or Without Ipilimumab in Treating Patients With Refractory/Relapsed or Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Bilineal LeukemiaAcute Biphenotypic LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome+6 more
M.D. Anderson Cancer Center 150
Testing effectiveness (Phase 2)Looking for participantsNCT04925479
What this trial is testing

Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia

Who this might be right for
Myeloid Leukemia, Philadelphia Positive
Novartis Pharmaceuticals 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT03399773
What this trial is testing

Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes

Who this might be right for
Acute Biphenotypic LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 Positive+3 more
Fred Hutchinson Cancer Center 31
Testing effectiveness (Phase 2)Ended earlyNCT00392782
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Masonic Cancer Center, University of Minnesota 24
Post-approval studies (Phase 4)Study completedNCT01043874
What this trial is testing

Study to Evaluate Nilotinib in Chronic Myelogenous Leukemia (CML) Patients With SubOptimal Response

Who this might be right for
Philadelphia Chromosome PositiveChronic Myelogenous Leukemia in Chronic Phase
Novartis Pharmaceuticals 45
Next Page
2,000